Joe Talamo has joined biopharmaceutical company NeoStem as vice president, corporate controller and chief accounting officer. Previously he held senior positions at OSI Pharmaceuticals as its vice president and corporate controller.

Prior to OSI, Joe worked at Bristol-Myers Squibb’s financial reporting and consolidations group, and at KPMG in the health care and life sciences audit group.  He also served as treasurer of OSI Pharmaceuticals Foundation.